1. Sulphasalazine: A Review of 40 Years’ Experience

   • Geoffrey Watkinson

   OriginalPaper 17 October 2012 Pages: 1 - 11

2. History of the Development of Sulphasalazine in Rheumatology

   • B. McConkey

   OriginalPaper 17 October 2012 Pages: 12 - 17

3. Pharmacological and Biochemical Actions of Sulphasalazine

   • J. R. S. Hoult

   Section 1: Mode of Action 17 October 2012 Pages: 18 - 26

4. 5-Aminosalicylic Acid or Sulphapyridine

   • Allister J. Taggart
   • Vera C. Neumann
   • Jonathan S. Dixon

   Section 1: Mode of Action 17 October 2012 Pages: 27 - 34

5. Effect of Non-Steroidal Anti-Inflammatory Drugs on the Human Small Intestine

   • I. Bjarnason
   • G. Zanelli
   • A. J. Levi

   Section 1: Mode of Action 17 October 2012 Pages: 35 - 41

6. Discussion: Section 1

   • H. L. F. Currey

   Section 1: Mode of Action 17 October 2012 Pages: 42 - 43

7. Comparison of White Blood Cell Dyscrasias during Sulphasalazine Therapy of Rheumatoid Arthritis and Inflammatory Bowel Disease

   • H. A. Capell
   • T. Pullar
   • J. A. Hunter

   Section 2: Toxicity and Acetylator Status 17 October 2012 Pages: 44 - 48

8. Side Effect Profile of 200 Patients with Inflammatory Arthritides Treated with Sulphasalazine

   • M. Farr
   • D. G. I. Scott
   • P. A. Bacon

   Section 2: Toxicity and Acetylator Status 17 October 2012 Pages: 49 - 53

9. Variables Affecting Efficacy and Toxicity of Sulphasalazine in Rheumatoid Arthritis

   • T. Pullar
   • H. A. Capell

   Section 2: Toxicity and Acetylator Status 17 October 2012 Pages: 54 - 57

10. Sulphasalazine for Rheumatoid Arthritis

    • R. S. Amos
    • D. E. Bax
    • M. S. Greaves

    Short Communication/Section 2: Toxicity and Acetylator Status 17 October 2012 Pages: 58 - 58

11. Discussion: Section 2

    • H. L. F. Currey

    Section 2: Toxicity and Acetylator Status 17 October 2012 Pages: 59 - 62

12. Assessing the Progression of Joint Damage in Rheumatoid Arthritis

    • D. L. Scott
    • M. Farr

    Section 3: Outcome Measures and Long Term Assessment 17 October 2012 Pages: 63 - 70

13. Long Term Outcome of Treatment with Sulphasalazine in Rheumatoid Arthritis

    • R. D. Situnayake
    • B. McConkey

    Short Communication/Section 3: Outcome Measures and Long Term Assessment 17 October 2012 Pages: 71 - 72

14. Sulphasalazine in the Long Term Management of Rheumatoid Arthritis

    • D. E. Bax
    • R. S. Amos

    Section 3: Outcome Measures and Long Term Assessment 17 October 2012 Pages: 73 - 76

15. Discussion: Section 3

    • H. L. F. Currey

    Section 3: Outcome Measures and Long Term Assessment 17 October 2012 Pages: 77 - 79

16. Closing Remarks

    • H. L. F. Currey

    OriginalPaper 17 October 2012 Pages: 80 - 80